Diatos

Diatos is a biopharmaceutical company founded in 1999, with its headquarters located in Paris, France, and two subsidiaries based in Leuven, Belgium, and the San Francisco Bay Area in the United States. Diatos focuses on researching, developing, and marketing new versions of existing anticancer chemotherapy drugs with enhanced tumor targeting or improved biodistribution. Diatos has built its portfolio of drugs and candidates through a strategy of license acquisitions and internal R&D activities based on its prodrug technologies, Vectocell® and Tumor-Selective Prodrugs (TSP).